How Did These 10 Predictions By Jim Cramer Turn Out?

Page 5 of 10

6. Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)

Number of Hedge Fund Holders: 21

A caller brought up Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), a biotech company focused on psychedelic treatments for mental health. Cramer said he was supportive back then, particularly of companies tackling pain and addiction:

“I like MindMed. I am a big believer in that, by the way. I’m in Vertex too. Anything, I’m into it, anything that makes it so that there’s ways to be able to get rid of pain and do good without getting people hooked, I am all in on. Does it necessarily mean it’ll make a lot of money? I don’t care. I think that people have to recognize this is an unmet need and it will make money in the end.”

Cramer’s optimism was not rewarded, as the stock dropped 22.97% despite his belief in its long-term potential.

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) is a clinical-stage biotech firm developing psychedelic-inspired treatments for mental health and addiction disorders.

Page 5 of 10